Hospice Care in Batesville, MS
6 Hospice found. Showing 1 - 6
 Baptist Memorial Home Care & Hospice-north Ms Medicare Approved Location: 548 Highway 6 East, Batesville, Mississippi 38606 Phone: (662) 578-8402 |
Halcyon Hospice- Batesville Medicare Approved Location: 270 Power Drive, Batesville, Mississippi 38606 Phone: (662) 561-0902 |
Mid Delta Hospice Of Batesville Medicare Approved Location: 112 Highway 51 North, Batesville, Mississippi 38606 Phone: (662) 563-1021 |
Grenada North Delta Hospice & Palliative Services Medicare Approved Location: 457 Hwy 6 E / Mail- Po Box 1798, Southaven 38671, Batesville, Mississippi 38606 Phone: (662) 563-5015 |
Legacy Hospice Of The South - Batesville Medicare Approved Location: 103 Woodland Road, Suite 7-d, Batesville, Mississippi 38606 Phone: (662) 578-8177 |
Grace Hospice ( Batesville) Medicare Approved Location: 510 Highway 51 South, Suite 4, Batesville, Mississippi 38606 Phone: (662) 563-2919 |
News Archive
Elsevier announces Gray's Anatomy Art Contest winners
Elsevier, a world-leading provider of scientific, technical and medical information products and services, and publisher of Gray's Anatomy, the world's most famous anatomical reference, has selected Amanda Lilleston of Ann Arbor, Mich., as the winner of the Gray's Anatomy Art Contest. Christopher Smith of Silver Springs, Md., was named runner-up.
Injury Sciences launches WrExpert Pro for scientific analysis of vehicle damages related auto injury claims
During its annual industry conference Injury Sciences LLC announced the release of WrExpert Pro™, the next and most advanced generation of software for the scientific analysis of vehicle damages and related auto injury claims. WrExpert Pro™ leverages data integration with client systems and leading third party technology providers and, with little or no manual data entry, delivers a biomechanical analysis that includes assessments of vehicle impact forces and occupant injury potential.
New recommendations on the use of intra-articular therapies
Intra-articular therapies (IAT) are frequently used to treat joint conditions such as gout, rheumatoid arthritis, or osteoarthritis.
FDA meeting confirms Orexo regulatory submission of OX219 NDA on track
A meeting with the US regulatory agency FDA held on July 17 has confirmed that the Swedish pharmaceutical company Orexo is on track with its preparation for a regulatory submission of a new drug approval (NDA) for its medicine for treatment of opioid dependency, OX219.
University of Greenwich's lecture on resistance training and health to be held on April 27
The University of Greenwich's School of Science is holding a free public lecture on resistance training and health, at 6.30pm on Wednesday, April 27 at the Medway campus.
› Verified 9 days ago